CELLPHIRE THERAPEUTICS
Live / Registered — Registered (as of 06 Sept 2022)
What this means for you
Registered since 06 Sept 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88701790
- Registration number
- 6839878
- Mark type
- Design + words
- Filed
- 21 Nov 2019
- Published for opposition
- 14 Jul 2020
- Registered
- 06 Sept 2022
- Attorney of record
- Leesa N. Weiss
Goods and services
- Class 005 — Pharmaceuticals: Blood platelets and other blood components for medical use; chemical reagents comprising blood platelets and other blood components for medical or veterinary purposes
Owner
- Cellphire, Inc., Rockville, MD, US
- Cellphire, Inc., Rockville, MD, US
- Cellphire, Inc., Rockville, MD, US
Prior registrations
Prosecution history
- 06 Sept 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 06 Sept 2022 — REGISTERED-PRINCIPAL REGISTER
- 04 Aug 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 03 Aug 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 25 Jul 2022 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 25 Jul 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 25 Jul 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 25 Jul 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 25 Jul 2022 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 05 Jul 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 01 Jul 2022 — USE AMENDMENT FILED
- 01 Jul 2022 — TEAS STATEMENT OF USE RECEIVED
- 20 Apr 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Apr 2022 — SOU EXTENSION 3 GRANTED
- 08 Mar 2022 — SOU EXTENSION 3 FILED